Durable clearance of hepatitis B virus after allogeneic blood stem cell transplantation by adoptive immunity transfer and antiviral chemotherapy.
Groll
Andreas H
AH
Infectious Disease Research Program, Dept. of Pediatric Hematology and Oncology, University Children's Hospital Münster, Domagkstrasse 9a, 48129 Münster, Germany. grollan@mednet.uni-muenster.de
Baumann-Köhler
Margit
M
Storkebaum
Beate
B
Kühn
Joachim
J
Jürgens
Heribert
H
Vormoor
Josef
J
D019264:Adoptive Transfer; D000971:Antineoplastic Combined Chemotherapy Protocols; D002353:Carrier State; D002648:Child; D003131:Combined Modality Therapy; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006509:Hepatitis B / Q000175:diagnosis* / Q000276:immunology / Q000628:therapy*; D006514:Hepatitis B Surface Antigens / Q000032:analysis; D006515:Hepatitis B virus / Q000302:isolation & purification; D006801:Humans; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000276:immunology / Q000628:therapy*; D011379:Prognosis; D018570:Risk Assessment; D014184:Transplantation, Homologous; D016896:Treatment Outcome; D019562:Viral Load
D006514:Hepatitis B Surface Antigens